E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/7/2004 in the Prospect News PIPE Daily.

New Issue: Innovative Drug closes private placement for $18 million

By Sheri Kasprzak

Atlanta, Dec. 7 - Innovative Drug Delivery Systems Inc. said Tuesday it has closed a private placement for $18 million.

The company issued 6 million shares at $3 each.

Rodman & Renshaw LLC was the placement agent in the offering.

The company also announced Tuesday that it has merged with Intract Inc. In the merger, investors in Innovative Drug Delivery Systems' private placement will receive about 24% of Intract's outstanding shares.

Based in New York, Innovative Drug is a specialty pharmaceutical company.

Issuer:Innovative Drug Delivery Systems Inc.
Issue:Stock
Amount:$18 million
Shares:6 million
Price:$3.00
Warrants:No
Placement agent:Rodman & Renshaw LLC
Settlement date:Dec. 7

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.